By Ben Butkus

This article has been updated from a previous version to correct the name of the test.

Canadian molecular diagnostics firm Mitomics today launched its first product, the Prostate Core Mitomic Test for determining the presence of malignant cells in normal-appearing tissue in biopsy samples.

The laboratory-developed, quantitative PCR-based test is now available to physicians in the US through the company's CLIA lab in Aurora, Colo.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.